Engineering the AAV capsid to optimize vector-host-interactions

Current Opinion in Pharmacology

Volumn 24, Issue , 2015, Pages 94-104

  Büning, Hildegard ^a,b,c,d   Huber, Anke ^b,c,d   Zhang, Liang ^b,c,d   Meumann, Nadja ^b,c,d   Hacker, Ulrich ^e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e University Cancer Center Leipzig (UCCL)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ARTICLE; BIOENGINEERING; ENDOTHELIUM CELL; GENE TARGETING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOGENICITY; IN VIVO STUDY; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS CAPSID; VIRUS GENOME; VIRUS ISOLATION; VIRUS VIRULENCE; ANIMAL; CELL NUCLEUS; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM;

ANIMALS; CAPSID; CELL NUCLEUS; DEPENDOVIRUS; GENETIC THERAPY; GENETIC VECTORS; HOST-PATHOGEN INTERACTIONS; HUMANS;

EID: 84939788603     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.08.002     Document Type: Article

References (76)

1. E. Hastie, and R.J. Samulski Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success - a personal perspective Hum Gene Ther 26 2015 257 265
2. G. Gao, L.H. Vandenberghe, M.R. Alvira, Y. Lu, R. Calcedo, X. Zhou, and J.M. Wilson Clades of Adeno-associated viruses are widely disseminated in human tissues J Virol 78 2004 6381 6388
3. F. Mingozzi, and K.A. High Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges Nat Rev Genet 12 2011 341 355
4. K.B. Kaufmann, H. Buning, A. Galy, A. Schambach, and M. Grez Gene therapy on the move EMBO Mol Med 5 2013 1642 1661
5. Q. Xie, W. Bu, S. Bhatia, J. Hare, T. Somasundaram, A. Azzi, and M.S. Chapman The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy Proc Natl Acad Sci U S A 99 2002 10405 10410
6. M.A. Kotterman, and D.V. Schaffer Engineering adeno-associated viruses for clinical gene therapy Nat Rev Genet 15 2014 445 451
7. H.C. Levy, V.D. Bowman, L. Govindasamy, R. McKenna, K. Nash, K. Warrington, W. Chen, N. Muzyczka, X. Yan, T.S. Baker, and et al. Heparin binding induces conformational changes in Adeno-associated virus serotype 2 J Struct Biol 165 2009 146 156
8. B. Gerlach, J.A. Kleinschmidt, and B. Bottcher Conformational changes in adeno-associated virus type 1 induced by genome packaging J Mol Biol 409 2011 427 438
9. L.M. Drouin, and M. Agbandje-McKenna Adeno-associated virus structural biology as a tool in vector development Future Virol 8 2013 1183 1199
10. G.P. Gao, Y. Lu, X. Sun, J. Johnston, R. Calcedo, R. Grant, and J.M. Wilson High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes J Virol 80 2006 6192 6194
11. M. Mietzsch, F. Broecker, A. Reinhardt, P.H. Seeberger, and R. Heilbronn Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans J Virol 88 2014 2991 3003
12. M. Nonnenmacher, and T. Weber Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway Cell Host Microbe 10 2011 563 576
13. S. Uhrig, O. Coutelle, T. Wiehe, L. Perabo, M. Hallek, and H. Buning Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis Gene Ther 19 2012 210 218
14. P.J. Xiao, and R.J. Samulski Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network J Virol 86 2012 10462 10473
15. F. Sonntag, S. Bleker, B. Leuchs, R. Fischer, and J.A. Kleinschmidt Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus J Virol 80 2006 11040 11054
16. K. Lux, N. Goerlitz, S. Schlemminger, L. Perabo, D. Goldnau, J. Endell, K. Leike, D.M. Kofler, S. Finke, M. Hallek, and et al. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking J Virol 79 2005 11776 11787
17. A. Girod, C.E. Wobus, Z. Zadori, M. Ried, K. Leike, P. Tijssen, J.A. Kleinschmidt, and M. Hallek The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity J Gen Virol 83 2002 973 978
18. R. Popa-Wagner, M. Porwal, M. Kann, M. Reuss, M. Weimer, L. Florin, and J.A. Kleinschmidt Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry J Virol 86 2012 9163 9174
19. L. Zhong, B. Li, C.S. Mah, L. Govindasamy, M. Agbandje-McKenna, M. Cooper, R.W. Herzog, I. Zolotukhin, K.H. Warrington Jr., K.A. Weigel-Van Aken, and et al. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses Proc Natl Acad Sci U S A 105 2008 7827 7832
20. B. Akache, D. Grimm, X. Shen, S. Fuess, S.R. Yant, D.S. Glazer, J. Park, and M.A. Kay A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8 Mol Ther 15 2007 330 339
21. L. Zhong, W. Zhao, J. Wu, B. Li, S. Zolotukhin, L. Govindasamy, M. Agbandje-McKenna, and A. Srivastava A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis Mol Ther 15 2007 1323 1330
22. L. Song, M.A. Kauss, E. Kopin, M. Chandra, T. Ul-Hasan, E. Miller, G.R. Jayandharan, A.E. Rivers, G.V. Aslanidi, C. Ling, and et al. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo Cytotherapy 15 2013 986 998
23. N. Gabriel, S. Hareendran, D. Sen, R.A. Gadkari, G. Sudha, R. Selot, M. Hussain, R. Dhaksnamoorthy, R. Samuel, N. Srinivasan, and et al. Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo Hum Gene Ther Methods 24 2013 80 93
24. A. Kern, K. Schmidt, C. Leder, O.J. Muller, C.E. Wobus, K. Bettinger, C.W. Von der Lieth, J.A. King, and J.A. Kleinschmidt Identification of a heparin-binding motif on adeno-associated virus type 2 capsids J Virol 77 2003 11072 11081
25. S.R. Opie, K.H. Warrington Jr., M. Agbandje-McKenna, S. Zolotukhin, and N. Muzyczka Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding J Virol 77 2003 6995 7006
26. R.C. Munch, H. Janicki, I. Volker, A. Rasbach, M. Hallek, H. Buning, and C.J. Buchholz Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer Mol Ther 21 2013 109 118
27. O.J. Muller, B. Leuchs, S.T. Pleger, D. Grimm, W.M. Franz, H.A. Katus, and J.A. Kleinschmidt Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors Cardiovasc Res 70 2006 70 78
28. R.C. Munch, A. Muth, A. Muik, T. Friedel, J. Schmatz, B. Dreier, A. Trkola, A. Pluckthun, H. Buning, and C.J. Buchholz Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors Nat Commun 6 2015 6246
29. H. Buning, L. Perabo, O. Coutelle, S. Quadt-Humme, and M. Hallek Recent developments in adeno-associated virus vector technology J Gene Med 10 2008 717 733
30. J.S. Bartlett, J. Kleinschmidt, R.C. Boucher, and R.J. Samulski Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab′gamma)2 antibody Nat Biotechnol 17 1999 181 186
31. S. Ponnazhagan, G. Mahendra, S. Kumar, J.A. Thompson, and M. Castillas Jr. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands J Virol 76 2002 12900 12907
32. M.D. Stachler, I. Chen, A.Y. Ting, and J.S. Bartlett Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase Mol Ther 16 2008 1467 1473
33. M.U. Ried, A. Girod, K. Leike, H. Buning, and M. Hallek Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors J Virol 76 2002 4559 4566
34. Y. Liu, Y. Fang, Y. Zhou, E. Zandi, C.L. Lee, K.I. Joo, and P. Wang Site-specific modification of adeno-associated viruses via a genetically engineered aldehyde tag Small 9 2013 421 429
35. M. Horner, B. Kaufmann, G. Cotugno, E. Wiedtke, H. Buning, D. Grimm, and W. Weber A chemical switch for controlling viral infectivity Chem Commun 50 2014 10319 10322
36. J. Boucas, K. Lux, A. Huber, S. Schievenbusch, M.J. von Freyend, L. Perabo, S. Quadt-Humme, M. Odenthal, M. Hallek, and H. Buning Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations J Gene Med 11 2009 1103 1113
37. K. Varadi, S. Michelfelder, T. Korff, M. Hecker, M. Trepel, H.A. Katus, J.A. Kleinschmidt, and O.J. Muller Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors Gene Ther 19 2012 800 809
38. S. Michelfelder, K. Varadi, C. Raupp, A. Hunger, J. Korbelin, C. Pahrmann, S. Schrepfer, O.J. Muller, J.A. Kleinschmidt, and M. Trepel Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo PLoS ONE 6 2011 e23101
39. H. Buning, M.U. Ried, L. Perabo, F.M. Gerner, N.A. Huttner, J. Enssle, and M. Hallek Receptor targeting of adeno-associated virus vectors Gene Ther 10 2003 1142 1151
40. M. Naumer, R. Popa-Wagner, and J.A. Kleinschmidt Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction J Gen Virol 93 2012 2131 2141
41. L. Perabo, D. Goldnau, K. White, J. Endell, J. Boucas, S. Humme, L.M. Work, H. Janicki, M. Hallek, A.H. Baker, and et al. Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism J Virol 80 2006 7265 7269
42. L.M. Work, S.A. Nicklin, N.J. Brain, K.L. Dishart, D.J. Von Seggern, M. Hallek, H. Buning, and A.H. Baker Development of efficient viral vectors selective for vascular smooth muscle cells Mol Ther 9 2004 198 208
43. S.A. Nicklin, H. Buening, K.L. Dishart, M. de Alwis, A. Girod, U. Hacker, A.J. Thrasher, R.R. Ali, M. Hallek, and A.H. Baker Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells Mol Ther 4 2001 174 181
44. A. Girod, M. Ried, C. Wobus, H. Lahm, K. Leike, J. Kleinschmidt, G. Deleage, and M. Hallek Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 Nat Med 5 1999 1438
45. L. Perabo, J. Endell, S. King, K. Lux, D. Goldnau, M. Hallek, and H. Buning Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus J Gene Med 8 2006 155 162
46. N. Maheshri, J.T. Koerber, B.K. Kaspar, and D.V. Schaffer Directed evolution of adeno-associated virus yields enhanced gene delivery vectors Nat Biotechnol 24 2006 198 204
47. S. Maersch, A. Huber, H. Buning, M. Hallek, and L. Perabo Optimization of stealth adeno-associated virus vectors by randomization of immunogenic epitopes Virology 397 2010 167 175
48. P. Asuri, M.A. Bartel, T. Vazin, J.H. Jang, T.B. Wong, and D.V. Schaffer Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells Mol Ther 20 2012 329 338
49. D. Grimm, J.S. Lee, L. Wang, T. Desai, B. Akache, T.A. Storm, and M.A. Kay In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses J Virol 82 2008 5887 5911
50. J.T. Koerber, J.H. Jang, and D.V. Schaffer DNA shuffling of adeno-associated virus yields functionally diverse viral progeny Mol Ther 16 2008 1703 1709
51. L. Lisowski, A.P. Dane, K. Chu, Y. Zhang, S.C. Cunningham, E.M. Wilson, S. Nygaard, M. Grompe, I.E. Alexander, and M.A. Kay Selection and evaluation of clinically relevant AAV variants in a xenograft liver model Nature 506 2014 382 386
52. L. Perabo, H. Buning, D.M. Kofler, M.U. Ried, A. Girod, C.M. Wendtner, J. Enssle, and M. Hallek In vitro selection of viral vectors with modified tropism: the adeno-associated virus display Mol Ther 8 2003 151 157
53. O.J. Muller, F. Kaul, M.D. Weitzman, R. Pasqualini, W. Arap, J.A. Kleinschmidt, and M. Trepel Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors Nat Biotechnol 21 2003 1040 1046
54. J. Sallach, G. Di Pasquale, F. Larcher, N. Niehoff, M. Rubsam, A. Huber, J. Chiorini, D. Almarza, S.A. Eming, H. Ulus, and et al. Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy Mol Ther 22 2014 929 939
55. T. Cronin, L.H. Vandenberghe, P. Hantz, J. Juttner, A. Reimann, A.E. Kacso, R.M. Huckfeldt, V. Busskamp, H. Kohler, P.S. Lagali, and et al. Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter EMBO Mol Med 6 2014 1175 1190
56. F. Sonntag, K. Schmidt, and J.A. Kleinschmidt A viral assembly factor promotes AAV2 capsid formation in the nucleolus Proc Natl Acad Sci U S A 107 2010 10220 10225
57. C. Summerford, and R.J. Samulski Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J Virol 72 1998 1438 1445
58. G. Seisenberger, M.U. Ried, T. Endress, H. Buning, M. Hallek, and C. Brauchle Real-time single-molecule imaging of the infection pathway of an adeno-associated virus Science 294 2001 1929 1932
59. C. Summerford, J.S. Bartlett, and R.J. Samulski AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection Nat Med 5 1999 78 82
60. A. Asokan, J.B. Hamra, L. Govindasamy, M. Agbandje-McKenna, and R.J. Samulski Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry J Virol 80 2006 8961 8969
61. M. Stiefelhagen, L. Sellner, J.A. Kleinschmidt, A. Jauch, S. Laufs, F. Wenz, W.J. Zeller, S. Fruehauf, and M.R. Veldwijk Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line Genet Vaccines Ther 6 2008 12
62. L. Sellner, M. Stiefelhagen, J.A. Kleinschmidt, S. Laufs, F. Wenz, S. Fruehauf, W.J. Zeller, and M.R. Veldwijk Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells Exp Hematol 36 2008 957 964
63. S. Michelfelder, J. Kohlschutter, A. Skorupa, S. Pfennings, O. Muller, J.A. Kleinschmidt, and M. Trepel Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries PLoS ONE 4 2009 e5122
64. Y. Ying, O.J. Muller, C. Goehringer, B. Leuchs, M. Trepel, H.A. Katus, and J.A. Kleinschmidt Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library Gene Ther 17 2010 980 990
65. K. Adachi, and H. Nakai A new recombinant adeno-associated virus (AAV)-based random peptide display library system: infection-defective Aav1.9-3 as a novel detargeted platform for vector evolution Gene Ther Regul 5 2010 31 55
66. S. Marsch, A. Huber, M. Hallek, H. Buning, and L. Perabo A novel directed evolution method to enhance cell-type specificity of adeno-associated virus vectors Comb Chem High Throughput Screen 13 2010 807 812
67. J.H. Jang, J.T. Koerber, J.S. Kim, P. Asuri, T. Vazin, M. Bartel, A. Keung, I. Kwon, K.I. Park, and D.V. Schaffer An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells Mol Ther 19 2011 667 675
68. D. Dalkara, L.C. Byrne, R.R. Klimczak, M. Visel, L. Yin, W.H. Merigan, J.G. Flannery, and D.V. Schaffer In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous Sci Transl Med 5 2013 189ra176
69. M. Trepel, J. Korbelin, E. Spies, M.B. Heckmann, A. Hunger, B. Fehse, H.A. Katus, J.A. Kleinschmidt, O.J. Muller, and S. Michelfelder Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors Gene Ther 2015
70. W. Li, A. Asokan, Z. Wu, T. Van Dyke, N. DiPrimio, J.S. Johnson, L. Govindaswamy, M. Agbandje-McKenna, S. Leichtle, D.E. Redmond Jr., and et al. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles Mol Ther 16 2008 1252 1260
71. L. Yang, J. Jiang, L.M. Drouin, M. Agbandje-McKenna, C. Chen, C. Qiao, D. Pu, X. Hu, D.Z. Wang, J. Li, and et al. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection Proc Natl Acad Sci U S A 106 2009 3946 3951
72. K.J. Excoffon, J.T. Koerber, D.D. Dickey, M. Murtha, S. Keshavjee, B.K. Kaspar, J. Zabner, and D.V. Schaffer Directed evolution of adeno-associated virus to an infectious respiratory virus Proc Natl Acad Sci U S A 106 2009 3865 3870
73. R.R. Klimczak, J.T. Koerber, D. Dalkara, J.G. Flannery, and D.V. Schaffer A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Muller cells PLoS ONE 4 2009 e7467
74. J.T. Koerber, R. Klimczak, J.H. Jang, D. Dalkara, J.G. Flannery, and D.V. Schaffer Molecular evolution of adeno-associated virus for enhanced glial gene delivery Mol Ther 17 2009 2088 2095
75. C.A. Maguire, D. Gianni, D.H. Meijer, L.A. Shaket, H. Wakimoto, S.D. Rabkin, G. Gao, and M. Sena-Esteves Directed evolution of adeno-associated virus for glioma cell transduction J Neurooncol 96 2010 337 347
76. S.J. Gray, B.L. Blake, H.E. Criswell, S.C. Nicolson, R.J. Samulski, T.J. McCown, and W. Li Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB) Mol Ther 18 2010 570 578